Stammdaten
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Unternehmen & Branche
| Name | BriaCell Therapeutics Corp. |
|---|---|
| Ticker | BCTX |
| CIK | 0001610820 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 7,6 Mio. USD |
| Beta | 1,63 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-01-31 | 10-Q | -7,221,820 | -2.58 | 33,594,454 | ||
| 2025-10-31 | 10-Q | -8,197,565 | -4.35 | 13,075,050 | ||
| 2025-07-31 | 10-K | -26,311,867 | -62.19 | 21,649,706 | ||
| 2025-04-30 | 10-Q | -6,126,902 | -1.64 | 17,001,798 | ||
| 2025-01-31 | 10-Q | -6,291,420 | -23.31 | 9,363,567 | ||
| 2024-10-31 | 10-Q | -5,802,175 | -32.67 | 10,414,330 | ||
| 2024-07-31 | 10-K | -4,791,466 | -43.68 | 5,872,261 | ||
| 2024-04-30 | 10-Q | 1,715,759 | 1.61 | 6,203,266 | ||
| 2024-01-31 | 10-Q | -11,294,603 | -10.64 | 12,231,047 | ||
| 2023-10-31 | 10-Q | 6,001,543 | -0.50 | 18,619,235 | ||
| 2023-07-31 | 10-K | -20,302,394 | -1.30 | 27,163,577 | -3,777,181 | |
| 2023-04-30 | 10-Q | -4,895,436 | -0.32 | 29,721,868 | -5,892,342 | |
| 2023-01-31 | 10-Q | -11,881,762 | -0.77 | 34,161,267 | -1,280,586 | |
| 2022-10-31 | 10-Q | -1,106,541 | -0.07 | 38,450,320 | 10,334,332 | |
| 2022-07-31 | 10-K | -26,838,903 | -1.73 | 42,577,041 | 10,328,932 | |
| 2022-04-30 | 10-Q | -10,015,573 | -0.65 | 9,958,452 | ||
| 2022-01-31 | 10-Q | 11,160,507 | 0.04 | 16,425,698 | ||
| 2021-10-31 | 10-Q | -27,533,485 | 1,583,777 | |||
| 2021-07-31 | 10-K | -13,816,200 | 58,043,762 | 27,671,721 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.